XETRA - Delayed Quote EUR

MEDICLIN Aktiengesellschaft (MED.DE)

Compare
2.5600 -0.0400 (-1.54%)
At close: November 22 at 5:36 PM GMT+1
Loading Chart for MED.DE
DELL
  • Previous Close 2.6000
  • Open 2.5200
  • Bid 2.4200 x 425000
  • Ask 2.5200 x 239700
  • Day's Range 2.4600 - 2.5600
  • 52 Week Range 2.2800 - 3.0000
  • Volume 8,597
  • Avg. Volume 1,134
  • Market Cap (intraday) 121.6M
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2400
  • Earnings Date Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 30, 2019
  • 1y Target Est 4.75

MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, vascular medicine, otorhinolaryngology, cardiac medicine, rheumatology, pain medicine, trauma surgery, urology, and others. The company also provides services in the areas of ENT and acute outpatient services. It owns clinics, rehabilitation care, nursing care facilities, and medical care centers in German federal states. The company was incorporated in 1994 and is headquartered in Offenburg, Germany.

www.mediclin.de

6,882

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MED.DE

View More

Performance Overview: MED.DE

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MED.DE
6.57%
DAX P
15.35%

1-Year Return

MED.DE
3.03%
DAX P
21.52%

3-Year Return

MED.DE
36.32%
DAX P
19.57%

5-Year Return

MED.DE
52.15%
DAX P
47.08%

Compare To: MED.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MED.DE

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    121.60M

  • Enterprise Value

    458.80M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.16

  • Price/Book (mrq)

    0.57

  • Enterprise Value/Revenue

    0.62

  • Enterprise Value/EBITDA

    4.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.46%

  • Return on Assets (ttm)

    2.82%

  • Return on Equity (ttm)

    -5.01%

  • Revenue (ttm)

    765.95M

  • Net Income Avi to Common (ttm)

    -11.15M

  • Diluted EPS (ttm)

    -0.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    129.99M

  • Total Debt/Equity (mrq)

    224.58%

  • Levered Free Cash Flow (ttm)

    20.47M

Research Analysis: MED.DE

View More

Company Insights: MED.DE

Research Reports: MED.DE

View More

People Also Watch